Exelixis (EXEL) Operating Income Growth (5y) (2015 - 2026)
Exelixis (EXEL) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | Exelixis | 14.52 Bn | 13.75 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 124.13% |
| Jan 2, 2026 | 57.46% |
| Oct 3, 2025 | 49.85% |
| Jul 4, 2025 | 23.11% |
| Apr 4, 2025 | 28.75% |
| Jan 3, 2025 | 16.12% |
| Sep 27, 2024 | 3.31% |
| Jun 28, 2024 | 24.56% |
| Mar 29, 2024 | -19.01% |
| Dec 29, 2023 | -6.03% |
| Sep 29, 2023 | -16.44% |
| Jun 30, 2023 | -1.92% |
| Mar 31, 2023 | -24.34% |
| Dec 30, 2022 | -26.85% |
| Sep 30, 2022 | 0.35% |
| Jul 1, 2022 | 25.29% |
| Apr 1, 2022 | 32.76% |
| Oct 1, 2021 | 48.02% |
| Jul 2, 2021 | 47.13% |
| Apr 2, 2021 | 37.71% |